Early Recognition of Renal Toxicity of High-dose Methotrexate Therapy A Case Report

被引:10
作者
Nowicki, Theodore Scott [1 ]
Bjornard, Kari [1 ]
Kudlowitz, David [1 ]
Sandoval, Claudio [1 ]
Jayabose, Somasundaram [1 ]
机构
[1] Maria Fareri Childrens Hosp, New York Med Coll, Dept Pediat, Div Pediat Hematol Oncol, Valhalla, NY 10595 USA
关键词
high-dose methotrexate; HDMTX; renal toxicity; carboxypeptidase G; leucovorin; osteosarcoma;
D O I
10.1097/MPH.0b013e318182e73e
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 10-year-old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending renal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4-hour infusion of high-dose methotrexate (MTX) (12g/m(2)), and went on to develop acute renal failure with life-threatening hyperkalemia 29 hours later. Although his renal function recovered completely with high-dose leucovorin, hemodialysis, charcoal hemoperfusion, and carboxypeptidase G2, we present this case to emphasize that signs of renal toxicity may be present as early as 2 hours after the completion of a 4-hour MTX infusion, and to Suggest that monitoring for MTX toxicity should perhaps begin within a few hours after the completion of 4-hour MTX infusion.
引用
收藏
页码:950 / 952
页数:3
相关论文
共 10 条
  • [1] Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure
    Buchen, S
    Ngampolo, D
    Melton, RG
    Hasan, C
    Zoubek, A
    Henze, G
    Bode, U
    Fleischhack, G
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (03) : 480 - 487
  • [2] Severe acute toxicity associated with high-dose methotrexate (MTX) therapy:: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation
    Esteve, M. -A.
    Devictor-Pierre, B.
    Galy, G.
    Andre, N.
    Coze, C.
    Lacarelle, B.
    Bernard, J. -L.
    Monjanel-Mouterde, S.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (01) : 39 - 42
  • [3] High-dose leucovorin as sole therapy for methotrexate toxicity
    Flombaum, CD
    Meyers, PA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1589 - 1594
  • [4] FRAPPAZ D, 1988, PRESSE MED, V17, P1209
  • [5] Influence of high-dose meth trexate therapy (HD-MTX) on glomerular and tubular kidney function
    Hempel, L
    Misselwitz, J
    Fleck, C
    Kentouche, K
    Leder, C
    Appenroth, D
    Rost, M
    Zintl, F
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 2003, 40 (06): : 348 - 354
  • [6] The effect of malignant effusions on methotrexate disposition
    Li, J
    Gwilt, P
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (05) : 373 - 382
  • [7] Effective removal of methotrexate by high-flux hemodialysis
    Saland, JM
    Leavey, PJ
    Bash, RO
    Hansch, E
    Arbus, GS
    Quigley, R
    [J]. PEDIATRIC NEPHROLOGY, 2002, 17 (10) : 825 - 829
  • [8] High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma - Incidence, treatment, and outcome
    Widemann, BC
    Balis, FM
    Kempf-Bielack, B
    Bielack, S
    Pratt, CB
    Ferrari, S
    Bacci, G
    Craft, AW
    Adamson, PC
    [J]. CANCER, 2004, 100 (10) : 2222 - 2232
  • [9] Carboxypeptidase-G(2), thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction
    Widemann, BC
    Balis, FM
    Murphy, RF
    Sorensen, JM
    Montello, MJ
    OBrien, M
    Adamson, PC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 2125 - 2134
  • [10] Understanding and managing methotrexate nephrotoxicity
    Widemann, Brigitte C.
    Adamson, Peter C.
    [J]. ONCOLOGIST, 2006, 11 (06) : 694 - 703